Structural requirements for centrally acting drugs. I. 1973

E J Lien, and G L Tong, and J T Chou, and L L Lien

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous

Related Publications

E J Lien, and G L Tong, and J T Chou, and L L Lien
February 1988, British medical journal (Clinical research ed.),
E J Lien, and G L Tong, and J T Chou, and L L Lien
January 1988, Journal of cardiovascular pharmacology,
E J Lien, and G L Tong, and J T Chou, and L L Lien
March 2004, Nihon rinsho. Japanese journal of clinical medicine,
E J Lien, and G L Tong, and J T Chou, and L L Lien
September 1968, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E J Lien, and G L Tong, and J T Chou, and L L Lien
January 1980, British journal of clinical pharmacology,
E J Lien, and G L Tong, and J T Chou, and L L Lien
January 1981, Annual review of pharmacology and toxicology,
E J Lien, and G L Tong, and J T Chou, and L L Lien
August 1962, Experientia,
E J Lien, and G L Tong, and J T Chou, and L L Lien
January 1980, Progress in biochemical pharmacology,
E J Lien, and G L Tong, and J T Chou, and L L Lien
January 1980, British journal of clinical pharmacology,
E J Lien, and G L Tong, and J T Chou, and L L Lien
November 1980, British medical journal,
Copied contents to your clipboard!